Austar Lifesciences Limited (6118.HK) HKSE

0.98

+0.01(+1.03%)

Updated at December 05 01:58PM

Currency In HKD

Valuation

Market Cap274.41M
Enterprise Value509.56M
P/E Ratio12.69
PEG Ratio0.11
Price/Sales Ratio0.31
Price/Book Ratio0.55
Enterprise/Revenue0.44
Enterprise/EBITDA8.84

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.02
Operating Margin0.04

Management Effectiveness

Return On Assets0.02
Return On Equity0.04

Income Statement

Revenue1.5B
Revenue/Share2.85
Gross Profit301.22M
EBITDA70.71M
Net Income16.08M
Diluted EPS0.03

Balance Sheet

Total Cash165.66M
Total Cash/Share0.32
Total Debt357.16M
Total Debt/Equity0.44
Current Ratio1.37
Book Value Per Share1.58

Price History

52-Week Change60
52-Week High1.97
52-Week Low0.45
Moving Average 50 Days1.09
Moving Average 200 Days0.98

Statistics

Average Volume473,650
Shares Outstanding512.58M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A